Insider Trading Activity For Aerpio Pharmaceuticals Inc (OTCMKTS:ARPO)
Bioventures Ltd Novartis , Major Shareholder of Aerpio Pharmaceuticals Inc (OTCMKTS:ARPO) reportedly Sold 117,140 shares of the company’s stock at an average price of 1.05 for a total transaction amount of $122,997.00 SEC Form
Insider Trading History For Aerpio Pharmaceuticals Inc (OTCMKTS:ARPO)
Analyst Ratings History For Aerpio Pharmaceuticals Inc (OTCMKTS:ARPO)
- On 7/23/2018 Needham & Company LLC Initiated Coverage of rating Buy with a price target of $10.00
- On 3/5/2019 Cantor Fitzgerald Set Price Target of rating Buy with a price target of $8.00
- On 3/18/2019 National Securities Downgraded rating Buy to Neutral
- On 3/18/2019 Guggenheim Downgraded rating Buy to Neutral
- On 4/5/2019 HC Wainwright Reiterated Rating Hold
Recent Trading Activity for Aerpio Pharmaceuticals Inc (OTCMKTS:ARPO)
Shares of Aerpio Pharmaceuticals Inc closed the previous trading session at with 26741 shares trading hands.